Pharmaceuticals, corporate crime and public health Graham Dukes; John Braithwaite; J.P. Moloney

By: Contributor(s): Material type: TextTextPublication details: Cheltenham Elgar 2015Description: IX, 408 SeitenContent type:
  • Text
Media type:
  • ohne Hilfsmittel zu benutzen
Carrier type:
  • Band
ISBN:
  • 9781784713614
  • 1784713619
  • 9781783471096
  • 1783471093
Subject(s): DDC classification:
  • 338.4/76151
LOC classification:
  • HD9665.5
NLM classification:
  • QV 773
  • 2014 J-829
Online resources: Other related works: Online-Ausgabe
Contents:
Creating a medicine : why, how and how not -- Safe, unsafe and improper manufacturing practices -- Aggressive or misleading promotion -- The dark art of manipulation : the industry and its puppets -- Corruption, counterfeiting and fraud -- Pricing, monopolies, abuses and the law -- A criminological perspective on a worsening crisis -- Positive regulation : the complementary role of supports and sanctions -- A responsive criminal law of pharmaceuticals -- Privatizing enforcement -- A new capitalism : a new drug diplomacy.
Summary: "Offering a considered analysis of pharmaceutical rights and wrongs as they have developed over the last half-century, this book is rich in new insights for managers in the pharmaceutical industry, regulatory agencies and health advocates."--Dust jacketSummary: "The pharmaceutical industry must exist to serve the community, but over the years it has engaged repeatedly in corporate crime and anti-social behaviour, with the public footing the bill. This readable study by experts in medicine, law, criminology and public health, with deep experience of the industry, documents problems ranging from false advertising and counterfeiting to corruption, fraud and overpricing. It is a fresh and revealing look at the unacceptable pressures brought to bear on doctors, politicians, patients and the media. Uniquely, the book presents realistic and worldwide solutions for the future, with positive policies encouraging honest dealing, as well as partial privatization of enforcement and a transformation of science policy to develop the medicines that society needs most. The authors examine in turn each of the main facets of the pharmaceutical industry's activities--research, manufacturing, information, distribution and pricing--as well as some questionable aspects of its relationship with society. Offering a considered analysis of pharmaceutical rights and wrongs as they have developed, particularly over the last half-century, this book is rich in new insights for managers in the pharmaceutical industry, regulatory agencies and health agencies"--Publisher description
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Call number Copy number Status Date due Barcode
Books Books Odessa College Stacks 338.4 D877P (Browse shelf(Opens below)) 1 Available 51994001610502

Creating a medicine : why, how and how not -- Safe, unsafe and improper manufacturing practices -- Aggressive or misleading promotion -- The dark art of manipulation : the industry and its puppets -- Corruption, counterfeiting and fraud -- Pricing, monopolies, abuses and the law -- A criminological perspective on a worsening crisis -- Positive regulation : the complementary role of supports and sanctions -- A responsive criminal law of pharmaceuticals -- Privatizing enforcement -- A new capitalism : a new drug diplomacy.

"Offering a considered analysis of pharmaceutical rights and wrongs as they have developed over the last half-century, this book is rich in new insights for managers in the pharmaceutical industry, regulatory agencies and health advocates."--Dust jacket

"The pharmaceutical industry must exist to serve the community, but over the years it has engaged repeatedly in corporate crime and anti-social behaviour, with the public footing the bill. This readable study by experts in medicine, law, criminology and public health, with deep experience of the industry, documents problems ranging from false advertising and counterfeiting to corruption, fraud and overpricing. It is a fresh and revealing look at the unacceptable pressures brought to bear on doctors, politicians, patients and the media. Uniquely, the book presents realistic and worldwide solutions for the future, with positive policies encouraging honest dealing, as well as partial privatization of enforcement and a transformation of science policy to develop the medicines that society needs most. The authors examine in turn each of the main facets of the pharmaceutical industry's activities--research, manufacturing, information, distribution and pricing--as well as some questionable aspects of its relationship with society. Offering a considered analysis of pharmaceutical rights and wrongs as they have developed, particularly over the last half-century, this book is rich in new insights for managers in the pharmaceutical industry, regulatory agencies and health agencies"--Publisher description

Includes bibliographical references and index.

There are no comments on this title.

to post a comment.